1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)-
Gastrointestinal Cancer
National Cancer Institute (NCI)Small moleculePhase 1/2Dormant
CC
45/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 81/ 100
Competitive context
40 Active assets in the Gastrointestinal Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOROURACILUM Alliance for Clinical Trials in Oncology | Phase 2 | BB |
Calcium folinate pentahydrate Alliance for Clinical Trials in Oncology | Phase 2 | BB |
Eloxatin Alliance for Clinical Trials in Oncology | Phase 2 | BB |
Irinotecan Amgen | Phase 2 | BB |
DEXAMETHASONE Cedars-Sinai Medical Center | Phase 4 | BB |
View all 50 →
Same molecule, other indications
1H-3-BENZAZEPIN-7-OL, 5-(7-BENZOFURANYL)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-, (5S)- is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →